Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, 060-8648, Japan.
J Hum Genet. 2022 Oct;67(10):607-611. doi: 10.1038/s10038-022-01048-7. Epub 2022 May 24.
Silver-Russel syndrome (SRS) is a representative imprinting disorder (ID) characterized by growth failure and diagnosed by clinical features. Recently, international consensus has recommended using the Netchine-Harbison clinical scoring system (NH-CSS) as clinical diagnostic criteria. Loss of methylation of H19/IGF2:intergenic differentially methylated region (H19LOM) and maternal uniparental disomy chromosome 7 (UPD(7)mat) are common etiologies of SRS; however, other IDs, pathogenic variants (PVs) of genes, and pathogenic copy number variants (PCNVs) have been reported in patients meeting NH-CSS. To clarify the frequency and clinical characteristics of each etiology, we conducted (epi)genetic analysis in 173 patients satisfying NH-CSS. H19LOM and UPD(7)mat were identified in 34.1%. PCNVs, other IDs, and PVs were in 15.0%. Patients with all six NH-CSS items were most frequently observed with H19LOM and UPD(7)mat. This study confirmed the suitability of NH-CSS as clinical diagnostic criteria, the (epi)genetic heterogeneity of SRS, and showed the necessity of further discussion regarding the "SRS spectrum".
银-罗素综合征(SRS)是一种具有代表性的印迹疾病(ID),其特征是生长发育迟缓,通过临床特征进行诊断。最近,国际共识建议使用 Netchine-Harbison 临床评分系统(NH-CSS)作为临床诊断标准。H19/IGF2 基因间差异甲基化区(H19LOM)的甲基化缺失和 7 号染色体母源单亲二倍体(UPD(7)mat)是 SRS 的常见病因;然而,在符合 NH-CSS 的患者中,还报道了其他 IDs、基因的致病性变异(PVs)和致病性拷贝数变异(PCNVs)。为了阐明每种病因的频率和临床特征,我们对满足 NH-CSS 的 173 名患者进行了(epi)遗传分析。确定了 34.1%的 H19LOM 和 UPD(7)mat。15.0%存在 PCNVs、其他 IDs 和 PVs。具有所有六个 NH-CSS 项目的患者最常观察到 H19LOM 和 UPD(7)mat。本研究证实了 NH-CSS 作为临床诊断标准的适用性、SRS 的(epi)遗传异质性,并表明需要进一步讨论“SRS 谱”。